Calendrier des promotions DexCom, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise
DexCom, Inc., компания по производству медицинского оборудования, занимается проектированием, разработкой и коммерциализацией систем непрерывного мониторинга уровня глюкозы (CGM) в США и за рубежом. Компания предоставляет свои системы для использования людьми с диабетом, а также для использования поставщиками медицинских услуг.
Plus de détailsСайт | https://www.dexcom.com |
---|---|
P/E | 199.66 |
P/S | 13.68 |
P/BV | 22.87 |
EV/EBITDA | 126.96 |
EBITDA | 0.1645 |
Цена ао | 75.06 |
Выручка | 1.48 |
Див.доход ао | 0 |
ISIN | US2521311074 |
Число акций ао | 0.4255 млрд |
Валюта | usd |
IPO date | 2005-04-14 |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Валюта отчета | usd |
Changement de prix par jour: | +8.47% (69.21) |
---|---|
Changement de prix par semaine: | +8.12% (69.43) |
Changement de prix par mois: | +8% (69.51) |
Changement de prix sur 3 mois: | -34.5% (114.61) |
Changement de prix sur six mois: | -44.1% (134.3) |
Changement de prix par an: | -8.51% (82.05) |
Evolution du prix sur 3 ans: | -86.73% (565.9) |
Evolution du prix sur 5 ans: | -70.24% (252.21) |
Evolution des prix sur 10 ans: | +32.75% (56.55) |
Evolution des prix depuis le début de l'année: | -28.35% (104.77) |
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
Date de transaction | Date de divulgation | Insider | Taper | Prix | Volume | Quantité | Partagez jusqu'à, % | Partager après, % | Document |
---|---|---|---|---|---|---|---|---|---|
09.09.2024 | 11.09.2024 | Leach Jacob Steven EVP, Chief Operating Officer |
Vente | 69.15 | 51 586 | 746 | 0 | 0 | lien |
09.09.2024 | 11.09.2024 | Sylvain Jereme M EVP, Chief Financal Officer |
Vente | 69.15 | 51 586 | 746 | 0 | 0 | lien |
09.09.2024 | 11.09.2024 | Stern Sadie EVP, Chief HR Officer |
Vente | 69.15 | 29 458 | 426 | 0 | 0 | lien |
30.08.2024 | 03.09.2024 | Brown Michael Jon EVP, Chief Legal Officer |
Vente | 70 | 48 020 | 686 | 0 | 0 | lien |
31.07.2024 | 01.08.2024 | Brown Michael Jon EVP, Chief Legal Officer |
Vente | 69.55 | 45 347 | 652 | 0 | 0 | lien |
31.07.2024 | 31.07.2024 | MICHAEL BROWN Officer |
Achat | 69.55 | 45 347 | 652 | 0 | 0 | lien |
14.06.2024 | 18.06.2024 | Heller Bridgette P Director |
Vente | 113.55 | 113 550 | 1000 | 0 | 0 | lien |
15.05.2024 | 16.05.2024 | Dolan Matthew Vincent EVP Strategy and Corporate Dev |
Vente | 126.58 | 306 703 | 2423 | 0 | 0 | lien |
15.04.2024 | 16.04.2024 | Dolan Matthew Vincent EVP Strategy and Corporate Dev |
Vente | 137.81 | 274 242 | 1990 | 0 | 0 | lien |
08.04.2024 | 10.04.2024 | SAYER KEVIN R President CEO and Chairman |
Vente | 138.3 | 6 864 240 | 49633 | 0 | -0.01 | lien |
28.03.2024 | 29.03.2024 | Brown Michael Jon EVP Chief Legal Officer |
Vente | 140.04 | 367 465 | 2624 | 0 | 0 | lien |
20.02.2024 | 21.02.2024 | Sylvain Jereme M EVP Chief Financial Officer |
Vente | 116.73 | 392 563 | 3363 | 0 | 0 | lien |
11.12.2023 | 11.12.2023 | Stern Sadie EVP Chief Human Resources Offi |
Vente | 117.66 | 46 123 | 392 | 0 | 0 | lien |
01.12.2023 | 04.12.2023 | Brown Michael Jon EVP Chief Legal Officer |
Vente | 114.56 | 413 791 | 3612 | 0 | 0 | lien |
10.07.2023 | 10.07.2023 | Regan Barry J. EVP Operations |
Vente | 128.05 | 254 691 | 1989 | 0 | 0 | lien |
10.07.2023 | 10.07.2023 | Stern Sadie EVP Chief Human Resources Offi |
Vente | 128.05 | 50 196 | 392 | 0 | 0 | lien |
23.05.2023 | 23.05.2023 | Pacelli Steven Robert EVP Managing Director Dexcom V |
Vente | 118.65 | 48 884 | 412 | 0 | 0 | lien |
22.05.2023 | 23.05.2023 | Sylvain Jereme M EVP Chief Financial Officer |
Vente | 117.58 | 282 192 | 2400 | 0 | 0 | lien |
10.04.2023 | 11.04.2023 | Stern Sadie EVP Chief Human Resources Offi |
Vente | 112.35 | 44 154 | 393 | 0 | 0 | lien |
23.03.2023 | 27.03.2023 | Pacelli Steven Robert EVP Managing Director Dexcom V |
Vente | 116.4 | 633 449 | 5442 | 0 | 0 | lien |
23.02.2023 | 23.02.2023 | Pacelli Steven Robert EVP Managing Director Dexcom V |
Vente | 111.64 | 45 996 | 412 | 0 | 0 | lien |
22.02.2023 | 22.02.2023 | Sylvain Jereme M EVP Chief Financial Officer |
Vente | 114.54 | 274 896 | 2400 | 0 | 0 | lien |
08.12.2022 | 08.12.2022 | Flynn Paul R EVP Global Revenue |
Vente | 123.5 | 1 110 020 | 8988 | 0 | -0.01 | lien |
21.11.2022 | 22.11.2022 | Sylvain Jereme M EVP Chief Financial Officer |
Vente | 112.62 | 270 288 | 2400 | 0 | 0 | lien |
Établissements | Volume | Partager, % |
---|---|---|
Vanguard Group Inc | 44467463 | 11.53 |
Blackrock Inc. | 32726186 | 8.49 |
Baillie Gifford and Company | 16520313 | 4.29 |
State Street Corporation | 16198598 | 4.2 |
Capital Research Global Investors | 15296032 | 3.97 |
Sands Capital Management, LLC | 15058806 | 3.91 |
Capital World Investors | 9278685 | 2.41 |
Geode Capital Management, LLC | 8917255 | 2.31 |
FMR, LLC | 8112737 | 2.1 |
Nuveen Asset Management, LLC | 7492292 | 1.94 |
Superviseur | Titre d'emploi | Paiement | Année de naissance |
---|---|---|---|
Mr. Kevin Ronald Sayer | Executive Chairman, CEO & President | 2.22M | 1958 (66 années) |
Mr. Jereme M. Sylvain | Executive VP, CFO & Chief Accounting Officer | 841.14k | 1980 (44 année) |
Mr. Jacob Steven Leach | Executive VP & COO | 994.13k | 1978 (46 années) |
Mr. Sean Christensen | Director of Corporate Affairs & Head of Investor Relations | N/A | |
Mr. Matthew Dolan | Executive Vice President of Strategy, Corporate Development & Dexcom Labs | N/A | 1981 (43 année) |
Mr. Girish Naganathan | Executive VP & CTO | 423.92k | 1977 (47 années) |
Mr. Michael Jon Brown | Executive VP & Chief Legal Officer | 954.46k | 1970 (54 année) |
Ms. Leverne Marsh | Executive Vice President of Marketing | N/A | |
Ms. Teri Lawver | Executive VP & Chief Commercial Officer | 1967 (57 années) | |
Stacey Stewart | Senior VP & Chief Information Officer |
Adresse: United States, San Diego. CA, 6340 Sequence Drive - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.dexcom.com
Site web: https://www.dexcom.com